Marta Mosca

29.5k total citations · 4 hit papers
311 papers, 7.7k citations indexed

About

Marta Mosca is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Marta Mosca has authored 311 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 193 papers in Rheumatology, 83 papers in Pathology and Forensic Medicine and 73 papers in Immunology. Recurrent topics in Marta Mosca's work include Systemic Lupus Erythematosus Research (151 papers), Systemic Sclerosis and Related Diseases (63 papers) and Monoclonal and Polyclonal Antibodies Research (46 papers). Marta Mosca is often cited by papers focused on Systemic Lupus Erythematosus Research (151 papers), Systemic Sclerosis and Related Diseases (63 papers) and Monoclonal and Polyclonal Antibodies Research (46 papers). Marta Mosca collaborates with scholars based in Italy, United States and Germany. Marta Mosca's co-authors include Stefano Bombardieri, Chiara Tani, R Neri, Chiara Baldini, Linda Carli, Caroline Gordon, Bridget Griffiths, S Bombardieri, Rosaria Talarico and Michelle Petri and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Marta Mosca

292 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

2015 655 citations Marta Mosca et al. profile →
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

2018 356 citations Marta Mosca et al. profile →
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

2023 89 citations Marta Mosca et al. profile →
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

2023 79 citations Marta Mosca et al. profile →

Peers

Countries citing papers authored by Marta Mosca

Since Specialization

Citations

This map shows the geographic impact of Marta Mosca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Mosca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Mosca more than expected).

Fields of papers citing papers by Marta Mosca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Mosca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Mosca. The network helps show where Marta Mosca may publish in the future.

Co-authorship network of co-authors of Marta Mosca

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Mosca. A scholar is included among the top collaborators of Marta Mosca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Mosca. Marta Mosca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	O25 Lupus podocytopathy: a rare form of lupus nephritis – an Italian retrospective multicenter study 2024 ·SHILAP Revista de lepidopterología ·(unknown), Savino Sciascia, Marta Calatroni, Vincenzo L’Imperio, Francesco Reggiani, Roberta Fenoglio, Lorenza Maria Argolini, (unknown), Nicola Lepori, Fausta Catapano, Mariele Gatto, Chiara Tani, Domenico Santoro, Maria Gerosa, Marta Mosca, Dario Roccatello, Renato Alberto Sinico, Gabriella Moroni	0
2	Environment and systemic lupus erythematosus 2024 ·Clinical and Experimental Rheumatology ·(unknown), Dina Zucchi, Elena Elefante, Viola Signorini, (unknown), Chiara Stagnaro, Marta Mosca, Chiara Tani	4
3	Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s Syndrome 2024 ·Journal of Clinical Medicine ·Gaetano La Rocca, Francesco Ferro, Gianluca Sambataro, Elena Elefante, Giovanni Fulvio, (unknown), Michele Moretti, Chiara Romei, Marta Mosca, Chiara Baldini	2
4	Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral Centers 2024 ·Journal of Personalized Medicine ·Stefano Gentileschi, (unknown), Carla Gaggiano, Arianna Damiani, Linda Carli, Maurizio Benucci, Fabrizio Cantini, Laura Niccoli, Antonio Vitale, Caterina Baldi, Andrea Delle Sedie, Luca Cantarini, Marta Mosca, Bruno Frediani, Serena Guiducci	2
5	When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus 2024 ·Lupus Science & Medicine ·Chiara Tani, (unknown), (unknown), Viola Signorini, Dina Zucchi, (unknown), (unknown), Linda Carli, Elena Elefante, Francesco Ferro, (unknown), Maria Laura Manca, Marta Mosca	0
6	AB0558 ANIFROLUMAB IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS: A REAL-LIFE, MULTICENTER STUDY 2023 ·Annals of the Rheumatic Diseases ·Francesca Trentin, Chiara Tani, Alberto Cauli, Fulvia Ceccarelli, Francesco Ciccia, Fabrizio Conti, (unknown), Lorenzo Dagna, G. De Marchi, Giacomo Emmi, Serena Fasano, Mariele Gatto, Luca Moroni, (unknown), Matteo Piga, Margherita Zen, Marta Mosca	2
7	POS1461 ADVANTAGES OF DOPPLER IN LABIAL SALIVARY GLAND ULTRA-HIGH FREQUENCY ULTRASOUND: CORRELATIONS WITH HISTOLOGICAL INFLAMMATION, pSS DIAGNOSIS, DISEASE ACTIVITY, AND PROGNOSIS 2023 ·Annals of the Rheumatic Diseases ·Giovanni Fulvio, Francesco Ferro, Rossana Izzetti, (unknown), (unknown), (unknown), (unknown), (unknown), Marta Mosca, Chiara Baldini	1
8	LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature 2023 ·Archives of Osteoporosis ·(unknown), (unknown), Marta Mosca, Maurizio Mazzantini	3
9	Exploring disease perception in Behçet’s syndrome: combining a quantitative and a qualitative study based on a narrative medicine approach 2023 ·Orphanet Journal of Rare Diseases ·(unknown), Ilaria Palla, Valentina Lorenzoni, (unknown), Salvatore Pirri, (unknown), (unknown), Alessandra Bianco, (unknown), (unknown), Giuseppe Turchetti, Marta Mosca, Rosaria Talarico	4
10	Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 2023 ·Frontiers in Pharmacology ·Irma Convertino, Massimiliano Cazzato, (unknown), (unknown), Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, (unknown), Claudia Bartolini, (unknown), Valentina Lorenzoni, Leopoldo Trieste, Matteo Filippi, Giuseppe Turchetti, (unknown), Corrado Blandizzi, Marta Mosca, Ersilia Lucenteforte, Marco Tuccori	0
11	Adherence to medication during pregnancy in systemic autoimmune diseases: results from a prospective study 2023 ·Clinical and Experimental Rheumatology ·Dina Zucchi, (unknown), Linda Carli, Elena Elefante, (unknown), Chiara Tani, Marta Mosca	1
12	COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology 2023 ·Lupus Science & Medicine ·(unknown), (unknown), Laura Andréoli, Micaela Fredi, Claudia Lomater, Luca Moroni, Marta Mosca, Bernd Raffeiner, Greta Carrara, (unknown), Davide Rozza, Anna Zanetti, Carlo Alberto Scirè, Gian Domenico Sebastiani	2
13	The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus 2023 ·Best Practice & Research Clinical Rheumatology ·Elena Elefante, Alain Cornet, Jeanette Andersen, (unknown), Marta Mosca	3
14	AB1020 MUSCULOSKELETAL INVOLVEMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS: A MONOCENTRIC EXPERIENCE 2023 ·Annals of the Rheumatic Diseases ·Andrea Delle Sedie, L. Ceccarelli, Francesco Costa, (unknown), (unknown), Marta Mosca, (unknown)	1
15	AB1258 CAMURATI-ENGELMANN DISEASE: EFFICACY OF ANTI-TNFALFA TREATMENT 2023 ·Annals of the Rheumatic Diseases ·(unknown), G. De Mattia, Marta Mosca, Maurizio Mazzantini	0
16	Differentiating between UCTD and early-stage SLE: from definitions to clinical approach 2021 ·Nature Reviews Rheumatology ·Savino Sciascia, Dario Roccatello, Massimo Radin, Ioannis Parodis, Jinoos Yazdany, Guillermo Pons‐Estel, Marta Mosca	33
17	Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 2021 ·Journal of Clinical Medicine ·Irma Convertino, (unknown), Rosa Gini, Massimiliano Cazzato, Marco Fornili, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Claudia Bartolini, (unknown), (unknown), Laura Baglietto, Giuseppe Turchetti, Leopoldo Trieste, Valentina Lorenzoni, Corrado Blandizzi, Marta Mosca, Marco Tuccori, Ersilia Lucenteforte	3
18	Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey 2020 ·RMD Open ·Rosaria Talarico, (unknown), Stefano Bombardieri, Gerd R Burmester, João Eurico Fonseca, Charissa Frank, Ilaria Galetti, É. Hachulla, Frédéric Houssiau, Ulf Müeller-Ladner, Matthias Schneider, Vanessa Smith, Giuseppe Turchetti, Jacob M. van Laar, Ana Vieira, Maurizio Cutolo, Marta Mosca	8
19	Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort 2020 ·Annals of the Rheumatic Diseases ·Francesca Saccon, Margherita Zen, Mariele Gatto, Domenico Paolo Emanuele Margiotta, Antonella Afeltra, Fulvia Ceccarelli, Fabrizio Conti, Alessandra Bortoluzzi, Marcello Govoni, Giulia Frontini, Gabriella Moroni, Francesca Dall’Ara, Anǵela Tincani, Viola Signorini, Marta Mosca, Anna Chiara Frigo, Luca Iaccarino, Andrea Doria	29
20	Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables 2018 ·Therapeutics and Clinical Risk Management ·Laura Niccoli, Carlotta Nannini, Corrado Blandizzi, Stefania Mantarro, Marta Mosca, Ombretta Di Munno, Delia Goletti, Maurizio Benucci, Francesca Li Gobbi, Emanuele Cassarà, O. Kaloudi, Fabrizio Cantini	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact